Loading clinical trials...
Loading clinical trials...
The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
UCB Biopharma SRL
NCT06312644 · Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, and more
NCT07247279 · Rare Diseases, Generalized Myasthenia Gravis (gMG)
NCT06055959 · Generalized Myasthenia Gravis
NCT06149559 · Generalized Myasthenia Gravis
NCT04833894 · Generalized Myasthenia Gravis
Mg0011 41
Mobile, Alabama
Mg0011 116
Phoenix, Arizona
Mg0011 31
Irvine, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions